Recombinant Human IL17F Protein，His

Interleukin-17F (IL-17F) is a cytokine belonging to the IL-17 family, primarily produced by T helper 17 (Th17) cells, and plays a critical role in mediating inflammatory responses. Its involvement in various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis, has attracted significant research interest. IL-17F acts by binding to its receptor, leading to the activation of downstream signaling pathways that ultimately influence the expression of pro-inflammatory cytokines and chemokines. This process contributes to the recruitment of immune cells and the exacerbation of inflammatory conditions. Given its pivotal role in immune responses, IL-17F has emerged as a potential therapeutic target. Researchers have focused on the development of recombinant IL-17F proteins for studying its biological effects and mechanisms of action in inflammatory diseases. Additionally, these recombinant proteins serve as tools for designing inhibitors that could modulate IL-17F activity, offering prospects for new treatment strategies. Understanding the structure-function relationship of IL-17F through recombinant protein studies can lead to innovations in therapeutic interventions for IL-17F-mediated diseases, facilitating the development of more effective and specific treatments. Overall, research on recombinant IL-17F not only enhances our understanding of immune regulation but also paves the way for novel clinical applications in managing chronic inflammatory conditions.